Cue Biopharma, Inc. (CUE)
26.96
-1.48
(-5.20%)
USD |
NASDAQ |
Sep 02, 16:00
26.96
0.00 (0.00%)
Pre-Market: 08:13
Cue Biopharma Research and Development Expense (TTM) : 76.97M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 76.97M |
| March 31, 2026 | 35.80M |
| December 31, 2025 | 37.43M |
| September 30, 2025 | 28.14M |
| June 30, 2025 | 32.84M |
| March 31, 2025 | 34.55M |
| December 31, 2024 | 36.29M |
| September 30, 2024 | 39.90M |
| June 30, 2024 | 40.26M |
| March 31, 2024 | 41.25M |
| December 31, 2023 | 40.28M |
| September 30, 2023 | 40.69M |
| June 30, 2023 | 38.23M |
| March 31, 2023 | 37.09M |
| December 31, 2022 | 37.67M |
| September 30, 2022 | 37.96M |
| June 30, 2022 | 41.68M |
| Date | Value |
|---|---|
| March 31, 2022 | 40.77M |
| December 31, 2021 | 40.50M |
| September 30, 2021 | 36.77M |
| June 30, 2021 | 33.05M |
| March 31, 2021 | 32.45M |
| December 31, 2020 | 32.59M |
| September 30, 2020 | 31.57M |
| June 30, 2020 | 29.36M |
| March 31, 2020 | 28.11M |
| December 31, 2019 | 26.60M |
| September 30, 2019 | 26.48M |
| June 30, 2019 | 31.54M |
| March 31, 2019 | 30.14M |
| December 31, 2018 | 27.64M |
| September 30, 2018 | 29.91M |
| June 30, 2018 | 23.67M |
| March 31, 2018 | 19.78M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 86.86M |
| Fortress Biotech, Inc. | 1.186M |
| Equillium, Inc. | 8.577M |
| Legend Biotech Corp. | 397.18M |
| Nurix Therapeutics, Inc. | 332.34M |